INCISIVE GENETICS

Incisive Genetics (IG) is committed to discovering and developing novel and potentially curative therapies for serious genetic diseases... Incisive Genetics Inc. (IG) is a Canadian biotech firm that is focused on developing its innovative lipid nanoparticle (LNP) delivery platform for genetic therapies. We believe the proprietary Incisive Delivery System™ provides a solution to the most critical challenge to effective CRISPR-based gene therapy - the effective and safe delivery of active gene editing machinery into in vivo target tissues... Incisive Genetics has secured the exclusive worldwide license from the University of British Columbia to the foundational Incisive Delivery System™ (IDS) and continues to build out its intellectual property and patent portfolio through additional research and development. Currently, we are focused on continued development of the IDS platform for therapeutic gene editing cargos.

Also known as: Incisive Genetics Inc.

Primary location: Vancouver Canada